Spot the theme........
U.S. Sen. Charles Grassley asked U.S. regulators on Thursday to investigate whether drugmaker GlaxoSmithKline withheld data about a risk of suicide linked to its anxiety disorder drug Paxil.
Grassley, a Republican from Iowa, said in a letter that a British regulatory agency had found Glaxo knew Paxil was associated with a higher risk of suicidal behavior in adolescents as far back as 1998.
"I would like you to take a look at the information that agency gathered and determine if the company has withheld safety information here as well," Grassley wrote in the letter to the heads of the U.S. Department of Health and Human Services and the Food and Drug Administration.
Reuters
No comments:
Post a Comment